A | B | C | D | E | F | G | H | CH | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg){kind=small} COVID-19 portal |
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose.[1][2] While 4.19 million vaccines were then being administered daily, only 22.3 percent of people in low-income countries had received at least a first vaccine by September 2022, according to official reports from national health agencies, which are collated by Our World in Data.[3]
During a pandemic on the rapid timeline and scale of COVID-19 cases in 2020, international organizations like the World Health Organization (WHO) and Coalition for Epidemic Preparedness Innovations (CEPI), vaccine developers, governments, and industry evaluated the distribution of the eventual vaccine(s).[4] Individual countries producing a vaccine may be persuaded to favor the highest bidder for manufacturing or provide first-class service to their own country.[5][6][7] Experts emphasize that licensed vaccines should be available and affordable for people at the frontlines of healthcare and in most need.[5][7]
In April 2020, it was reported that the UK agreed to work with 20 other countries and global organizations, including France, Germany, and Italy, to find a vaccine and share the results, and that UK citizens would not get preferential access to any new COVID‑19 vaccines developed by taxpayer-funded UK universities.[8] Several companies planned to initially manufacture a vaccine at artificially low prices, then increase prices for profitability later if annual vaccinations are needed and as countries build stock for future needs.[7]
The WHO had set out the target to vaccinate 40% of the population of all countries by the end of 2021 and 70% by mid-2022,[9] but many countries missed the 40% target at the end of 2021.[10][11]
Distribution
Note about table in this section: Number and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens, which can push totals beyond 100% of the local population. Table is updated daily by a bot.[note 1]
| Location | Vaccinated[a] | Percent[b] | |
|---|---|---|---|
|
World[c][d] | 5,631,262,370 | 70.61% |
|
China[e] | 1,310,292,000 | 91.89% |
|
India | 1,027,438,576 | 72.50% |
|
European Union[f] | 338,119,395 | 75.11% |
|
United States[g] | 270,227,181 | 81.39% |
|
Indonesia | 203,878,473 | 74.00% |
|
Brazil | 189,643,431 | 88.08% |
|
Pakistan | 165,567,890 | 70.21% |
|
Bangladesh | 151,507,151 | 88.50% |
|
Japan | 104,705,133 | 84.47% |
|
Mexico | 97,179,493 | 76.22% |
|
Nigeria | 92,261,510 | 42.22% |
|
Vietnam | 90,272,853 | 91.94% |
|
Russia | 89,081,596 | 61.56% |
|
Philippines | 78,484,848 | 67.92% |
|
Iran | 65,199,831 | 73.63% |
|
Germany | 64,876,299 | 77.82% |
|
Turkey | 57,941,051 | 67.89% |
|
Thailand | 57,005,497 | 79.62% |
|
Egypt | 56,907,319 | 51.27% |
|
France | 54,677,678 | 80.63% |
|
United Kingdom | 53,806,963 | 79.97% |
|
Italy[h] | 50,936,719 | 86.28% |
|
South Korea | 44,784,499 | 86.43% |
|
Ethiopia | 44,073,766 | 35.72% |
|
Colombia | 43,012,174 | 82.92% |
|
Argentina | 41,529,058 | 91.25% |
|
Spain | 41,351,234 | 86.95% |
|
Myanmar | 34,777,314 | 64.64% |
|
Canada | 34,763,194 | 90.40% |
|
Tanzania | 34,434,933 | 52.57% |
|
Peru | 30,563,708 | 89.76% |
|
Malaysia | 28,138,179 | 82.91% |
|
Nepal | 27,883,196 | 91.28% |
|
Saudi Arabia | 27,041,364 | 74.27% |
|
Morocco | 25,020,168 | Zdroj:https://en.wikipedia.org?pojem=Deployment_of_COVID-19_vaccines